AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, intravasate into blood or lymphatic vessels, and extravasate into a distant tissue. Metastatic disease is primarily responsible for the low 5-year survival rate of non-small cell lung cancer (NSCLC), and therefore, an understanding of the molecular mechanisms that regulate NSCLC metastasis is clearly warranted. The serine/threonine kinase and tumor suppressor LKB1 is mutated in 30% of NSCLC tumors, and recent evidence points to a prominent role in NSCLC metastasis. This review summarizes LKB1-dependent invasion pathways where compromised LKB1 function could promote NSCLC metastasis
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identi...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Abstract LKB1/STK11 is a tumor suppressor gene that was originally identified in an a...
AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, i...
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers s...
In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways ar...
LKB1 is the second most commonly altered tumour suppressor gene in lung adenocarcinoma, the most pre...
abstract: Non-small cell lung cancer (NSCLC) has become the leading cause of cancer-related deaths i...
Liver kinase B1 (LKB1) is a tumor suppressor gene whose inactivation is frequent in different tumor ...
LKB1 is among the most frequently altered tumor suppressors in lung adenocarcinoma. Inactivation of ...
STK11/LKB1, a serine/threonine protein kinase and tumor suppressor, is a key upstream kinase of aden...
LKB1 (also known as STK11) is a recently identified tumor suppressor gene whose mutation can lead to...
AbstractThe LKB1 tumor suppressor gene is frequently mutated in sporadic lung adenocarcinomas and ce...
cancer genetic alterations, studies defining the pathways deregulated in tumor progression and metas...
Germline mutations of the LKB1 tumor suppressor gene result in Peutz–Jeghers syndrome (PJS) charac-t...
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identi...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Abstract LKB1/STK11 is a tumor suppressor gene that was originally identified in an a...
AbstractMetastasis is characterized by the ability of cancer cells to invade into adjacent tissue, i...
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers s...
In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways ar...
LKB1 is the second most commonly altered tumour suppressor gene in lung adenocarcinoma, the most pre...
abstract: Non-small cell lung cancer (NSCLC) has become the leading cause of cancer-related deaths i...
Liver kinase B1 (LKB1) is a tumor suppressor gene whose inactivation is frequent in different tumor ...
LKB1 is among the most frequently altered tumor suppressors in lung adenocarcinoma. Inactivation of ...
STK11/LKB1, a serine/threonine protein kinase and tumor suppressor, is a key upstream kinase of aden...
LKB1 (also known as STK11) is a recently identified tumor suppressor gene whose mutation can lead to...
AbstractThe LKB1 tumor suppressor gene is frequently mutated in sporadic lung adenocarcinomas and ce...
cancer genetic alterations, studies defining the pathways deregulated in tumor progression and metas...
Germline mutations of the LKB1 tumor suppressor gene result in Peutz–Jeghers syndrome (PJS) charac-t...
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identi...
The kinase LKB1 is a tumor suppressor mutated in familial and sporadic human cancers, whose loss is ...
Abstract LKB1/STK11 is a tumor suppressor gene that was originally identified in an a...